# Phase I Trial of Periocular Topotecan in Retinoblastoma

> **NCT00460876** · PHASE1 · COMPLETED · sponsor: **Hospital JP Garrahan** · enrollment: 5 (actual)

## Conditions studied

- Retinoblastoma

## Interventions

- **DRUG:** Topotecan

## Key facts

- **NCT ID:** NCT00460876
- **Lead sponsor:** Hospital JP Garrahan
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2007-12
- **Final completion:** 2008-04
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2008-05-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00460876

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00460876, "Phase I Trial of Periocular Topotecan in Retinoblastoma". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00460876. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*